Mackenzie Financial’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Mackenzie Financial’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,194	Closed	-$378K	–	1138
2019 Q2	$378K	Sell	2,194 -2,115	-49%	-$366K	﹤0.01%	905
2019 Q1	$726K	Sell	4,309 -1,824	-30%	-$271K	﹤0.01%	973
2018 Q4	$597K	Sell	6,133 -290	-5%	-$38K	﹤0.01%	905
2018 Q3	$1.11M	Buy	6,423 +1,331	+26%	+$192K	﹤0.01%	741
2018 Q2	$711K	Buy	+5,092	New	+$723K	﹤0.01%	725

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mackenzie Financial's GWPH Position: Q3 2019 in Review

Mackenzie Financial sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2019, closing a stake of 2,194 shares — an estimated $378K sold.

Mackenzie Financial first reported a position in GWPH in Q2 2018 and held it in 5 quarters. The position peaked at $1.11M in Q3 2018. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.

Mackenzie Financial reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
Mackenzie Financial sold 2,194 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2019, an estimated $378K.
Mackenzie Financial first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 5 quarters.
Mackenzie Financial's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.11M in Q3 2018.
316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.

Based on Mackenzie Financial's 13F filing for Q3 2019, filed 14 Nov 2019.